Living Rheum

00:04:15

Early Arthritis Insights from the CATCH Cohort

Living Rheum ·

2026/04/30

Presenter: Louis Bessette MD, FRCP(C), MSc What can nearly two decades of real-world data teach us about optimizing care in early inflammatory arthritis? Find out with Dr. Louis Bessette as he reviews key findings from the Canadian Early Arthritis Cohort (CATCH), a national, multicenter study of nearly 4,000 patients enrolled within weeks of symptom onset. Not only is Dr. Bessette a Professor of Medicine at Université Laval and the Director of the Centre for Osteoporosis and

en

00:03:30

A Visual Guide to Cutaneous Dermatomyositis

Living Rheum ·

2026/04/30

Guest: Avery H. LaChance, MD, MPH, FAAD Cutaneous dermatomyositis has a distinct pattern of skin findings that, once recognized, can make diagnosis much more straightforward. Tune in to hear Dr. Avery H. LaChance walk through the key visual clues and exam tips that help bring this condition into focus. Dr. LaChance is Director of the Connective Tissue Disease Clinic, Director of the Advanced Psoriasis Therapeutics Clinic, Director of Health Policy and Advocacy, and Program Director of

en

00:01:45

Key Advances in Rheumatology at CCR East 2026

Living Rheum ·

2026/04/30

Presenter: Louis Bessette MD, FRCP(C), MSc From early arthritis treatment pathways to emerging digital health tools, the 2026 Congress of Clinical Rheumatology East conference spotlights the clinical and scientific advances shaping the future of rheumatology care. Joining us to outline those key themes and sessions is Dr. Louis Bessette, Professor of Medicine at Université Laval and the Director of the Centre for Osteoporosis and Rheumatology of Québec.

en

00:05:15

Spot the Difference: Acute vs. Subacute Cutaneous Lupus

Living Rheum ·

2026/04/30

Guest: Avery H. LaChance, MD, MPH, FAAD Acute and subacute cutaneous lupus each have recognizable skin presentations that can help guide diagnosis, especially when distinguishing them from similar conditions. Join Dr. Avery H. LaChance as she breaks down their key diagnostic features, common mimics, and important considerations for clinical evaluation. Dr. LaChance is Director of the Connective Tissue Disease Clinic, Director of the Advanced Psoriasis Therapeutics Clinic, Director of

en

00:02:45

Can We Prevent Psoriatic Arthritis Before Diagnosis?

Living Rheum ·

2026/01/30

Guest: Laura Coates, MBChB, MRCP, PhD As our understanding of psoriatic arthritis deepens, we're starting to turn our attention toward intervention: preventing the disease before it progresses or is officially diagnosed. Tune in to hear Dr. Laura Coates discuss the evolving landscape of psoriatic arthritis prevention and interception, including the challenges and opportunities in identifying at-risk patients and designing effective early intervention studies. Dr. Coates is an NIHR

en

00:03:30

Decoding the Data: Early Biologic Use and Psoriatic...

Living Rheum ·

2026/01/30

Guest: Laura Coates, MBChB, MRCP, PhD Can treating psoriasis early with biologics help prevent psoriatic arthritis? The data’s promising—but it’s complicated. Join Dr. Laura Coates as she unpacks the latest research, explaining how early intervention may influence outcomes and what real-world challenges come with interpreting observational data. Dr. Coates is an NIHR Research Professor and Senior Clinical Research Fellow at the University of Oxford in the United Kingdom.

en

00:03:15

Defining the Challenge in Complex Cases of Psoriatic...

Living Rheum ·

2026/01/30

Guest: Laura Coates, MBChB, MRCP, PhD Managing psoriatic arthritis gets more complex when patients don’t respond to standard treatments or present with overlapping conditions. Hear Dr. Laura Coates' insights on difficult-to-treat and complex-to-manage psoriatic arthritis—highlighting how clear classification can guide more targeted therapies, research, and support strategies for these often-overlooked patient populations. Dr. Coates is an NIHR Research Professor and Senior Clinical

en

00:11:00

Rethinking SLE Treatment: Recent Approvals, Novel...

Living Rheum ·

2025/12/09

Host: Steve Jackson, PharmD Guest: Marc Scherlinger, MD, PhD Systemic lupus erythematosus (SLE) treatment is undergoing a transformative shift from broad immunosuppression to targeted, precision-based approaches. Dr. Marc Scherlinger joins Dr. Steve Jackson to provide a timely update on recent breakthroughs, including monoclonal antibodies, JAK and BTK inhibitors, and CAR T-cell therapies, as well as challenges in translating novel therapies into clinical practice. Dr. Scherlinger

en

00:00:00

Understanding Preload Deficiency in SLE: A New Look...

Living Rheum ·

2025/11/06

Host: Ryan Quigley Guest: Luigi Adamo, MD, PhD Guest: Andrea Fava, MD Fatigue and exercise intolerance in patients with systemic lupus erythematosus (SLE) may persist even when disease activity is controlled, and preload deficiency could be an overlooked cause. In this expert-led discussion, Drs. Luigi Adamo and Andrea Fava share insights from their research, highlighting diagnostic clues, the role of NT-proBNP, and emerging interventions aimed at improving quality of

en

00:00:00

Exploring Cadherin-6: A Key Driver of Inflammation in...

Living Rheum ·

2025/10/24

Guest: Gary S. Firestein, MD Despite advances in biologics, many patients with rheumatoid arthritis still experience persistent inflammation. However, cadherin-6 has recently been identified as a potential treatment target. Hear from Dr. Gary Firestein as he explains the discovery, function, and therapeutic potential of cadherin-6 in rheumatoid arthritis pathogenesis. Dr. Firestein is a Distinguished Professor of Medicine and the Senior Associate Vice Chancellor for Health Sciences at

en

00:00:00

Cadherin-6 in Focus: Existing Antibodies, Emerging...

Living Rheum ·

2025/10/24

Guest: Gary S. Firestein, MD While cadherin-6 may not yet shift clinical practice in rheumatoid arthritis, its role as a surface-expressed, actionable target opens the door to rapid therapeutic development—particularly with existing antibodies already in clinical trials for urologic cancers. Dr. Gary Firestein discusses the potential for cadherin-6 to become a useful target across multiple diseases. Dr. Firestein is a Distinguished Professor of Medicine and the Senior Associate

en

00:00:00

Preventing Serious Infections in Immunocompromised...

Living Rheum ·

2025/09/25

Guest: Leonard H. Calabrese, DO Preventing serious infections should be a priority when treating patients with immune-mediated inflammatory diseases, especially those receiving immunosuppressive therapies. By assessing patients’ level of immunocompetence, clinicians can better tailor vaccination strategies and optimize infection prevention. Hear Dr. Leonard Calabrese discuss how to evaluate immunosuppression risk and coordinate timely vaccinations for patients undergoing

en

00:00:00

Rethinking Lupus Nephritis: Targeting Immune Dysfunction

Living Rheum ·

2025/09/25

Guest: Joan Merrill, MD Despite common misconceptions, lupus nephritis is part of a broader immune imbalance seen in systemic lupus, not a separate condition. This is why it's important to shift focus from organ-specific treatment to immune dysregulation targeting. Hear Dr. Joan Merrill, Professor at the Oklahoma Medical Research Foundation’s Arthritis and Clinical Immunology Research Program in Oklahoma City, discuss the spectrum of lupus and, based on that, considerations for

en

00:00:00

Rethinking Chronic Pain: A Biopsychosocial Approach...

Living Rheum ·

2025/09/22

Guest: Martin Cheatle, PhD Chronic pain is now recognized as a distinct disease that requires more than just a symptom-based approach. Lifestyle factors and psychological health are also important considerations for care, which is why a biopsychosocial approach can be key to better outcomes. Hear Dr. Martin Cheatle discuss the importance of this clinical mindset shift and practical strategies to help patients reduce suffering and improve function. Dr. Cheatle is an Associate Professor

en

00:00:00

Rethinking Chronic Pain: A Biopsychosocial Approach...

Living Rheum ·

2025/09/22

Guest: Martin Cheatle, PhD Chronic pain is now recognized as a distinct disease that requires more than just a symptom-based approach. Lifestyle factors and psychological health are also important considerations for care, which is why a biopsychosocial approach can be key to better outcomes. Hear Dr. Martin Cheatle discuss the importance of this clinical mindset shift and practical strategies to help patients reduce suffering and improve function. Dr. Cheatle is an Associate Professor

en

00:00:00

Diagnosing Long COVID: Rheumatologic Implications of...

Living Rheum ·

2025/09/15

Diagnosing long COVID continues to pose challenges for clinicians and patients alike. While 2024 diagnostic criteria from the National Academies aimed to make navigating it easier, the framework may raise some concerns, particularly for rheumatologists. Hear Ryan Quigley break down a commentary on the criteria published in July 2025 in Arthritis & Rheumatology that outlines why it may cause problems in the rheumatology community.

en

00:00:00

Rethinking Opioids: Key Considerations for Balancing...

Living Rheum ·

2025/05/13

Guest: Martin Cheatle, PhD A thoughtful, communicative, and compassionate approach to opioid use is essential for responsible patient use. Join Dr. Martin Cheatle as he explains the neuroscience of chronic pain, the psychosocial components often overlooked in these patients, and evidence-based strategies for evaluating risk and treatment response. Dr. Cheatle is the Director of Behavioral Medicine at the Penn Pain Medicine Center as well as an Associate Professor of Psychiatry,

en

00:00:00

Recognizing and Addressing Rheumatic irAEs from...

Living Rheum ·

2025/05/01

Guest: Laura Cappelli, MD, MHS,MS Patients who are receiving immunotherapy for cancer sometimes develop significant autoimmune complications, which can be fatal. Join Dr. Laura Cappelli, Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine, as she explains how multidisciplinary collaboration can help manage these rheumatic immune-related adverse events (irAEs). Dr. Cappelli also spoke about this topic at the 2025 Congress of Clinical

en

00:00:00

The Complexities Behind Lupus: Understanding its...

Living Rheum ·

2025/05/01

Guest: Michelle Kahlenberg, MD, PhD Lupus arises from a complex interaction of genetics, environmental stimuli, and immune system errors. Dive into the pathophysiology behind the disease with Dr. Michelle Kahlenberg, the Giles Boles and Dorothy Mulkey Research Professor of Rheumatology and Professor of Internal Medicine and Dermatology at the University of Michigan, as she examines the mechanisms that contribute to the development of autoreactive immune responses. Dr. Kahlenberg also

en

00:00:00

Tailoring Approaches to Pediatric Rheumatic Disease:...

Living Rheum ·

2025/05/01

Guest: John Bridges, MD, MS For children with rheumatic diseases, early diagnosis, personalized care, and multidisciplinary collaboration are critical for optimal long-term management. Join Dr. John Bridges, Assistant Professor in the Division of Pediatric Rheumatology at the University of Alabama at Birmingham Heersink School of Medicine, as he explains how access, timing, and collaboration shape pediatric rheumatology care. Dr. Bridges presented on this topic at the 2025 Congress of

en

All Episodes

Similar Podcasts

النشرة العلمية

مونت كارلو الدولية / MCD

Ciência

RFI Português

天方烨谈

基因频道

Quilo de Ciencia - Cienciaes.com

Jorge Laborda

The Field Guides

The Field Guides